Clinical Trials Open To Enrollment

• An 18-month trial investigating an oral medication targeting beta amyloid for individuals with mild to moderate Alzheimer’s disease. For more information, please visit the study Web site.

• An 8-month pilot study investigating coconut oil for individuals with mild to moderate Alzheimer’s disease. For more information. For more information, please see study flyer.

• A 4-month trial investigating an injection based medication for individuals with mild to moderate Alzheimer’s disease. For more information, please visit the study Web site.

• An 18-month trial investigating an infusion based medication for individuals with mild cognitive impairment and mild Alzheimer’s disease. For more information, please visit the study Web site.

• A 4-year observational study with examinations, imaging procedures, and testing for individuals with mild Alzheimer’s disease or in individuals who have a significant cognitive concern. Must be 65 or older to participate. For more information, please visit the study Web site.

• A study for caregivers looking to improve caregiver sleep and the effects of heart disease (caregivers do not have to have heart disease to participate, only have sleep problems due to caring for a loved one with dementia). The study includes a night monitoring system and therapy for improving sleep. For more information, please visit the study Web site.

• A brain fitness training program for individuals with mild cognitive impairment. Eligible participants receive 20 hours of brain fitness training at the Cognitive Aging Lab at USF.

For more information about these and other clinical trials at the USF Health Byrd Alzheimer's Institute, please contact Jill Smith, MA, CCRC at (813) 974-1294 or jsmith10@health.usf.edu.